SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (171)4/8/1998 10:20:00 PM
From: John O'Neill  Read Replies (3) of 3044
 
MCDE expected to meet all expenses from it's cash flow for next 5 years. In addition, they have about $3.50/ share cash which they can hold onto for after the 5 year period. Exceptional cash flow for a biotech...!!

I expect a LOT of publicity about resistant bacteria. This can truly become a panic situation..I have already begun to see this in the hospitals and skilled nursing facilities.

Bacteria share resistant genes and we're heading for trouble unless new approaches are forthcoming soon. Curing cancer would be a blessing, but if John Doe worker starts dropping dead of simple strep/staph this would attract attention not yet seen in the drug world. We have taken our antibiotics for granted; infections accounted for more than 1/2 of fatalities before penicillin was developed.

Forbes just had article April 6 & MCDE was at the top of it's short list.

JO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext